GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Mono Pharmacare Ltd (NSE:MONOPHARMA) » Definitions » Gross Margin %

Mono Pharmacare (NSE:MONOPHARMA) Gross Margin % : 8.95% (As of Sep. 2024)


View and export this data going back to 2023. Start your Free Trial

What is Mono Pharmacare Gross Margin %?

Gross Margin % is calculated as gross profit divided by its revenue. Mono Pharmacare's Gross Profit for the six months ended in Sep. 2024 was ₹78 Mil. Mono Pharmacare's Revenue for the six months ended in Sep. 2024 was ₹872 Mil. Therefore, Mono Pharmacare's Gross Margin % for the quarter that ended in Sep. 2024 was 8.95%.


The historical rank and industry rank for Mono Pharmacare's Gross Margin % or its related term are showing as below:

NSE:MONOPHARMA' s Gross Margin % Range Over the Past 10 Years
Min: 6.05   Med: 7.5   Max: 9.53
Current: 9.26


During the past 4 years, the highest Gross Margin % of Mono Pharmacare was 9.53%. The lowest was 6.05%. And the median was 7.50%.

NSE:MONOPHARMA's Gross Margin % is ranked worse than
94.59% of 628 companies
in the Healthcare Providers & Services industry
Industry Median: 40.685 vs NSE:MONOPHARMA: 9.26

Mono Pharmacare had a gross margin of 8.95% for the quarter that ended in Sep. 2024 => No sustainable competitive advantage

The 5-Year average Growth Rate of Gross Margin for Mono Pharmacare was 0.00% per year.


Mono Pharmacare Gross Margin % Historical Data

The historical data trend for Mono Pharmacare's Gross Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Mono Pharmacare Gross Margin % Chart

Mono Pharmacare Annual Data
Trend Mar21 Mar22 Mar23 Mar24
Gross Margin %
6.05 6.20 8.79 9.53

Mono Pharmacare Semi-Annual Data
Mar21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24
Gross Margin % Get a 7-Day Free Trial 6.25 10.49 9.37 9.74 8.95

Competitive Comparison of Mono Pharmacare's Gross Margin %

For the Pharmaceutical Retailers subindustry, Mono Pharmacare's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Mono Pharmacare's Gross Margin % Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Mono Pharmacare's Gross Margin % distribution charts can be found below:

* The bar in red indicates where Mono Pharmacare's Gross Margin % falls into.


;
;

Mono Pharmacare Gross Margin % Calculation

Gross Margin is the percentage of Gross Profit out of sales or Revenue.

Mono Pharmacare's Gross Margin for the fiscal year that ended in Mar. 2024 is calculated as

Gross Margin % (A: Mar. 2024 )=Gross Profit (A: Mar. 2024 ) / Revenue (A: Mar. 2024 )
=116.6 / 1223.402
=(Revenue - Cost of Goods Sold) / Revenue
=(1223.402 - 1106.76) / 1223.402
=9.53 %

Mono Pharmacare's Gross Margin for the quarter that ended in Sep. 2024 is calculated as


Gross Margin % (Q: Sep. 2024 )=Gross Profit (Q: Sep. 2024 ) / Revenue (Q: Sep. 2024 )
=78.1 / 871.628
=(Revenue - Cost of Goods Sold) / Revenue
=(871.628 - 793.576) / 871.628
=8.95 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.


Mono Pharmacare  (NSE:MONOPHARMA) Gross Margin % Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

Mono Pharmacare had a gross margin of 8.95% for the quarter that ended in Sep. 2024 => No sustainable competitive advantage


Be Aware

If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.


Mono Pharmacare Gross Margin % Related Terms

Thank you for viewing the detailed overview of Mono Pharmacare's Gross Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Mono Pharmacare Business Description

Traded in Other Exchanges
N/A
Address
1A, Krinkal Apartment, Opp. Mahalaxmi Temple, Paldi, Ahmedabad, GJ, IND, 380007
Mono Pharmacare Ltd is a distributor and supplier of a wide array of Pharmaceuticals products and medicines. The company offers Health Care products, Antibiotic medicines, Cough Cold Anti Allergic medicines, Antifungal medicines, Nutraceutical medicines, Analgesic & Antipyretic medicines, Antacid & Antiemetics medicines, Cardiac-Diabetic medicines, and cosmocare products.

Mono Pharmacare Headlines

No Headlines